Multinational specialty bio-pharmaceutical company.
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Re-authorization of the Pandemic and All-Hazards Preparedness Act; NDAA - provisions related to biological and chemical defense; Department of Defense appropriations for Medical Countermeasures; FDA regulatory issues; Issues related to Priority Review Voucher programs; Opioid and heroin addiction legislation, Naloxone access, co-prescribing/opioid prescribing guidelines.
HCR - Health Issues
134 - Centers For Disease Control & Prevention (CDC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 18 - Office of Management & Budget (OMB) 19 - Office of Natl Drug Control Policy (NDCP) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA)
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
EDWARD C. RENO DERRICK M WHITE (Deputy Communications Director, Senator Orrin) JEFFREY SADOSKY (Communications Director, Senator Rob Portman Communications Director, Senator Kay Bailey Hutchison Deputy Press Secretary, Senator Mike DeWine) JERRY DRISCOLL ZACHARY WILLIAMS WESLEY RYAN WELCH (Legislative Director, Senator Richard Shelby Legislative Assistant, Senator Richard Shelby Legislative Correspondent, Senator Richard Shelby) ELIZABETH GREER (Chief of Staff, Rep. Allen Boyd) RICK MURPHY (Chief of Staff, Senator Kelly Ayotte, April 14 - Jan. 17) KRISTINA DUNKLIN
Deputy Communications Director, Senator Orrin Communications Director, Senator Rob Portman Communications Director, Senator Kay Bailey Hutchison Deputy Press Secretary, Senator Mike DeWine Legislative Director, Senator Richard Shelby Legislative Assistant, Senator Richard Shelby Legislative Correspondent, Senator Richard Shelby Chief of Staff, Rep. Allen Boyd Chief of Staff, Senator Kelly Ayotte, April 14 - Jan. 17